Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Head of Division
Our Research
We aim to translate innovative science into patient benefit across a range of specialities, with a specific focus on immunology, stroke and non-invasive imaging combined with artificial intelligence/big data.
Read moreLatest publications
-
Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors.
Journal article
Ma K. et al, (2022), J Immunol
-
Major haemorrhage: past, present and future.
Journal article
Shah A. et al, (2022), Anaesthesia
-
IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses.
Journal article
Clement M. et al, (2022), Nat Commun, 13
-
Lymphatic endothelia stakeout cryptic stem cells.
Journal article
Antanaviciute A. et al, (2022), Cell Stem Cell, 29, 1292 - 1293
-
Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction.
Journal article
Hadjihambi A. et al, (2022), J Hepatol
COVID-19 research
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
What's new
Anjali Kusumbe receives the RMS Life Sciences Medal
29 September 2022
The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.
Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m
5 August 2022
Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.
Six RDM research groups secure LEAF Sustainability Awards
22 July 2022
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.